OncoDaily GU shared a post on LinkedIn:
“Welcome to OncoDaily GU!
Stay tuned for curated updates in genitourinary oncology, advancing conversations on prostate, bladder, kidney, testicular, and other GU cancer care, research, and innovation.
Follow OncoDaily GU for expert insights, clinical trial news, approvals, guidelines, and emerging treatment updates.”
Other articles on OncoDaily.